Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Similar articles for PubMed (Select 21657964)

1.

High-dose methotrexate in patients with primary central nervous system lymphoma: does drug exposure really matter?

Joerger M, Huitema AD, Illerhaus G, Ferreri AJ.

Leuk Lymphoma. 2011 Oct;52(10):1825-7. doi: 10.3109/10428194.2011.580027. Epub 2011 Jun 10. No abstract available.

PMID:
21657964
2.

What is the optimal dose of high-dose methotrexate in the initial treatment of primary central nervous system lymphoma?

Dalia S, Price S, Forsyth P, Sokol L, Jaglal M.

Leuk Lymphoma. 2015 Feb;56(2):500-2. doi: 10.3109/10428194.2014.927458. Epub 2014 Jul 17. No abstract available.

PMID:
24882264
3.

Relapse of primary central nervous system lymphoma 13 years after high-dose methotrexate-based polychemotherapy.

Steinbeck JA, Stuplich M, Blasius E, Pels H, Glas M, Schlegel U, Herrlinger U.

J Clin Neurosci. 2011 Nov;18(11):1554-5. doi: 10.1016/j.jocn.2011.04.003. Epub 2011 Aug 24.

PMID:
21868233
4.

Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy.

Morris PG, Abrey LE, Reiner AS, Wu N, Panageas KS, Seko BS, Deangelis LM, Omuro A.

Leuk Lymphoma. 2011 Oct;52(10):1891-7. doi: 10.3109/10428194.2011.585527. Epub 2011 Jun 24.

PMID:
21699456
5.

High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma.

Masaki Y, Miki M, Sun Y, Nakamura T, Iwao H, Nakajima A, Kurose N, Sakai T, Jin ZX, Sawaki T, Kawanami T, Fujita Y, Tanaka M, Fukushima T, Hirose Y, Umehara H.

Int J Hematol. 2011 Jun;93(6):720-6. doi: 10.1007/s12185-011-0848-1. Epub 2011 May 15.

PMID:
21573892
6.

Clinical importance of Bcl-6-positive non-deep-site involvement in non-HIV-related primary central nervous system diffuse large B-cell lymphoma.

Song MK, Chung JS, Joo YD, Lee SM, Oh SY, Shin DH, Yun EY, Kim SG, Seol YM, Shin HJ, Choi YJ, Cho GJ.

J Neurooncol. 2011 Sep;104(3):825-31. doi: 10.1007/s11060-011-0555-z. Epub 2011 Mar 6. Erratum in: J Neurooncol. 2011 Sep;104(3):833.

PMID:
21380743
7.

Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent patients.

Cohen IJ.

Pediatr Blood Cancer. 2011 Jul 1;56(7):1151. doi: 10.1002/pbc.23001. Epub 2011 Feb 10. No abstract available.

PMID:
21312324
8.

Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.

Moise L, Matta C, Hanna C, Pilorge S, Fermé C, Durrbach A, Ribrag V.

Leuk Lymphoma. 2011 Mar;52(3):521-4. doi: 10.3109/10428194.2010.536601. Epub 2010 Dec 6. No abstract available.

PMID:
21133726
9.

A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma.

Taoka K, Okoshi Y, Sakamoto N, Takano S, Matsumura A, Hasegawa Y, Chiba S.

Int J Hematol. 2010 Nov;92(4):617-23. doi: 10.1007/s12185-010-0703-9. Epub 2010 Oct 22.

PMID:
20967518
10.

Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy.

Khimani NB, Ng AK, Chen YH, Catalano P, Silver B, Mauch PM.

Ann Oncol. 2011 Apr;22(4):979-84. doi: 10.1093/annonc/mdq548. Epub 2010 Oct 8.

11.

Improved survival with combined chemo-radiotherapy in primary central nervous system lymphoma.

Abdelsalam M, El-Husseiny G, Akhtar S, Khafaga Y, Al-Shabana M, AlHusaini H, El Weshi A, Rahal M, Maghfoor I.

Hematol Oncol Stem Cell Ther. 2010;3(3):128-34.

12.

Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.

Shah AC, Kelly DR, Nabors LB, Oakes WJ, Hilliard LM, Reddy AT.

Pediatr Blood Cancer. 2010 Dec 1;55(6):1227-30. doi: 10.1002/pbc.22752.

PMID:
20882580
13.

Flows and flaws in primary central nervous system lymphoma.

Ferreri AJ, Illerhaus G, Zucca E, Cavalli F; International Extranodal Lymphoma Study Group.

Nat Rev Clin Oncol. 2010 Aug;7(8):doi:10.1038/nrclinonc.2010.9-c1; author reply doi:10:1038/nrclinonc.2010.9-c2. doi: 10.1038/nrclinonc.2010.9-c1. No abstract available.

PMID:
20700952
14.

[High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute].

Usui N, Dobashi N, Yano S, Yahagi Y, Takei Y, Otsubo H, Takahara S, Yamaguchi Y, Saito T, Minami J, Kamiyama Y, Morikawa N, Machishima T, Osawa H, Aiba K.

Gan To Kagaku Ryoho. 2010 Jul;37(7):1277-82. Japanese.

PMID:
20647709
15.

Hematology. Individualized methotrexate dosing in primary CNS lymphoma.

Abrey LE.

Nat Rev Clin Oncol. 2010 Jun;7(6):306-7. doi: 10.1038/nrclinonc.2010.66.

PMID:
20517339
16.

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.

Juergens A, Pels H, Rogowski S, Fliessbach K, Glasmacher A, Engert A, Reiser M, Diehl V, Vogt-Schaden M, Egerer G, Schackert G, Reichmann H, Kroschinsky F, Bode U, Herrlinger U, Linnebank M, Deckert M, Fimmers R, Schmidt-Wolf IG, Schlegel U.

Ann Neurol. 2010 Feb;67(2):182-9. doi: 10.1002/ana.21824.

PMID:
20225195
17.

Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy.

Kinoshita M, Hashimoto N, Izumoto S, Okita Y, Kagawa N, Maruno M, Ohnishi T, Arita N, Yoshimine T.

J Neurooncol. 2010 Aug;99(1):95-101. doi: 10.1007/s11060-010-0112-1. Epub 2010 Jan 13.

PMID:
20069343
18.

Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma.

Momota H, Narita Y, Maeshima AM, Miyakita Y, Shinomiya A, Maruyama T, Muragaki Y, Shibui S.

J Neurooncol. 2010 Jul;98(3):341-8. doi: 10.1007/s11060-009-0078-z. Epub 2009 Dec 13.

PMID:
20012911
19.

Primary central nervous system lymphoma: recent progress, many remaining questions.

Swinnen LJ.

Curr Opin Oncol. 2009 Sep;21(5):393-6. doi: 10.1097/CCO.0b013e32832f3cb7. Review.

PMID:
19593137
20.

A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma.

Uhm JE, Kim KH, Yi SY, Chang MH, Park KW, Kong DS, Lee JI, Nam do H, Park W, Lim do H, Kim SJ, Kim K, Ko YH, Kim WS.

Leuk Lymphoma. 2009 Jul;50(7):1110-8. doi: 10.1080/10428190902964776.

PMID:
19557631
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk